Navigation Links
'Chlamy' genome holds clues for renewable energy, the environment and human health
Date:10/11/2007

University of Minnesota researchers contributed to a national effort to sequence the genome of an ancient, one-celled organism that will help advance research in a broad range of areas, from biofuels to restoring the environment to understanding a variety of human diseases.

The organism, Chlamydomonas reinhardtii, known affectionately as Chlamy, has long fascinated scientists because it is an ancestor of plants and animals that retains characteristics of both. Like green plants, Chlamy (a type of green alga) uses photosynthesis to convert solar energy and carbon dioxide into biomass. And like many animal cells, including human sperm, it has flagella that allow it to swim.

Analysis of the 15,000 genes that make up Chlamys genome revealed hundreds that control photosynthesis and the function of flagella. The genome also provides a glimpse back through time to when all plants and animals were unicellular and used flagella to swim. When they became multicellular, plants put down roots and lost their flagella while animals retained flagella on certain kinds of cells, including sperm and cilia on some cells in the lungs, kidneys and eyes.

Led by the U.S. Department of Energys Joint Genome Institute, the University of California and the Carnegie Institute, the genome study is published in the Oct. 12 issue of Science.

Peter Lefebvre, Carolyn Silflow and Anton Sanderfoot, members of the department of plant biology faculty, were part of the national team of researchers that carried out the massive project. LeFebvre provided the DNA sample that launched the effort and Carolyn Silflow contributed a detailed molecular map that helped the team identify the function of hundreds of genes involved in photosynthesis and the formation of flagella. Students in the College of Biological Sciences also took part in the historic research.

We expect the work to produce new biological strategies for capturing solar energy, assimilating car
'/>"/>

Contact: Mark Cassutt
cassu003@umn.edu
612-624-8038
University of Minnesota
Source:Eurekalert

Page: 1 2

Related biology news :

1. Chlamydia parasite lives off our fat
2. Common ancestry of bacterium and plants could be key to an effective new treatment for chlamydia
3. Chlamydia vaccine a step closer to reality
4. Man and mouse share genome structures
5. Genome of deadly amoeba shows surprising complexity, evidence of lateral gene transfer
6. Affymetrix Unveils Plans to Double Plant and Animal Genome Microarray Offering
7. Whole genome fine map of rice completed
8. Genome-wide mouse study yields link to human leukemia
9. Study finds more than one-third of human genome regulated by RNA
10. A bacterial genome reveals new targets to combat infectious disease
11. Scientists decipher genome of fungus that can cause life-threatening infections
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... , March 5, 2015 In Brazil ... of companies already using these solutions and 42 percent planning ... the latter, approximately 25 percent of the companies will be ... While the majority of companies in the region are currently ... the hybrid model will command significant attention in the coming ...
(Date:3/3/2015)... LAKE FOREST, Calif. , March 3, ... ("Company"), the leading provider of advanced cryogenic ... serving markets including immunotherapies, stem cells, cell ... health, and reproductive medicine, today announced the ... Hutchinson Cancer Research Centers, ("Fred Hutch") ...
(Date:3/2/2015)... Ala. , March 2, 2015  Businesses ... processing. Data protection company Tharon Rankins Enterprises has ... that provides an ultra-safe way for businesses to ... their financial transactions. Beconux is ... Tharon Rankins Enterprises. Functioning similarly to an ATM ...
Breaking Biology News(10 mins):Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 2Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 3Two of Every Three Brazilian Companies will have Invested in Cloud by 2015, Finds Frost & Sullivan 4Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3Personal Data Protection Company Launches New Product 2
... detection is critical for improving cancer survival rates. Yet, ... lung cancer, is notoriously difficult to detect in its ... to detect lung cancer by merely shining diffuse light ... new clinical study, the analysis technique--called partial wave spectroscopic ...
... Many scientists aspire to take control over the stem cell ... perfectly matched to each patient in the future. Now research ... SAGE-Hindawi, explains how engineering the topography on which stem cells ... as powerful an agent for change as their chemical environment. ...
... BOZEMAN, Mont. -- Invasive plants make life tougher for ... of the Missouri River Basin, so why not turn the ... time? Russian olive and saltcedar alone could supply biomass ... region. Converting invasive plants to fuel is an ...
Cached Biology News:Cheek swab may detect lung cancer 2Cheek swab may detect lung cancer 3Stem cells shape up to their surroundings 2Stem cells shape up to their surroundings 3Montana State, partners in 6 states consider converting invasive plants to fuel 2Montana State, partners in 6 states consider converting invasive plants to fuel 3Montana State, partners in 6 states consider converting invasive plants to fuel 4
(Date:3/25/2015)... Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; OTCQX: ... with certain shareholders representing approximately 45% of the outstanding ... certain matters including the appointment of auditors at its ... 2015 (the "Meeting") it intends to adjourn the Meeting ... when the Meeting reconvenes. The Meeting will be reconvened ...
(Date:3/25/2015)... , March 25, 2015  S&P Capital IQ ... Factual Stock Report coverage on Abattis Bioceuticals Corp ... CSE: ATT): is a specialty biotechnology company with ... licensing and marketing proprietary ingredients, bio-similar compounds, patented ... North America . The company ...
(Date:3/25/2015)... SHANGHAI , CAMBRIDGE, Mass. and ... -- WuXi NextCODE, which provides comprehensive capabilities for using the ... deCODE genetics on their publication of the largest studies of ... published today online in Nature Genetics ... date of sequence variation, authored by a team of deCODE ...
(Date:3/25/2015)... San Francisco, CA (PRWEB) March 25, 2015 ... Provide Support for Novel Mechanism of Action in ... March 25, 2015 – Cytokinetics, Incorporated (Nasdaq: CYTK) ... its fast skeletal muscle troponin activator tirasemtiv in ... from a Phase IIa “Evidence of Effect” or ...
Breaking Biology Technology:SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 2SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 3SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 4SQI Diagnostics Inc. Announces New Nominees to SQI Diagnostics Board and Adjournment of Meeting 5S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6
... , , ... , , , ... example protein arrays) or as biopharmaceutical therapeutics. In,all cases the ... key quality criteria include: protein identification,quantitation and the monitoring of ...
... , ... , , , When working ... transfection of small interfering RNA (siRNA),into a cell, the presence of having ... be of great value.,Three to four siRNA sequences are generally tested for ...
... , , ... , , This Application Note ... can be used to detect cell surface,and intracellular protein targets by ... on CCRF-CEM cells and intracellular,glucocorticoid receptor (GR) staining of H4 rat ...
Cached Biology Technology:Quality control of antibodies using the,2100 bioanalyzer and the Protein 200,Plus assay 2Quality control of antibodies using the,2100 bioanalyzer and the Protein 200,Plus assay 3siRNA transfection optimization,with the Agilent 2100 bioanalyzer 2siRNA transfection optimization,with the Agilent 2100 bioanalyzer 3siRNA transfection optimization,with the Agilent 2100 bioanalyzer 4siRNA transfection optimization,with the Agilent 2100 bioanalyzer 5siRNA transfection optimization,with the Agilent 2100 bioanalyzer 6siRNA transfection optimization,with the Agilent 2100 bioanalyzer 7Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 2Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 3Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 4Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 5Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 6Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 7Detection of antibody-stained cell,surface and intracellular protein targets,with the Agilent 2100 bioanalyzer 8
... whose sequence corresponds to residues 1-18 from rat rab 3D. ... - A - S - A - S - E - ... - D - A - A - D - Q - ... control experiments with the polyclonal antibody that reacts with this product ...
Rabbit polyclonal antibody to Glutathione-S-Transferase (GST)...
... Assay Kit contains all reagents necessary to ... lineage, as determined by staining for mineralization. ... necessary reagents and a protocol for quantifying ... product is useful for studying the effects ...
... discovery races ever faster, you need a partner ... So our constant focus is on providing tools ... why our Biomek 3000 Laboratory Automation Workstation offers ... it is flexible. By integrating all aspects of ...
Biology Products: